Company profile: Celltrio
1.1 - Company Overview
Company description
- Provider of cell culturing automation and biobanking solutions via RoboCell, a cell line automation platform for cell maintenance, culture and screening; Bioflow, software to define, schedule, execute and monitor workflows with real-time data tracking; and RoboStor, automated LN2 storage for biobanking and cryogenic applications, standalone or integrated with RoboCell.
Products and services
- RoboCell: An automated cell line platform that handles cell maintenance, culture, passage, differentiation, transformation, cell line development, biobanking, assays, imaging, and screening
- RoboStor: A robotic liquid nitrogen storage system for R&D, biobanking, and cryogenic applications, usable stand-alone or integrated into RoboCell to support LN2-based cryogenic operations
- Bioflow: Visual-interface software that defines, schedules, executes, and monitors cell culture processes and workflows, delivering real-time data management and tracking
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Celltrio
Echelon Biosciences
HQ: United States
Website
- Description: Provider of tools and reagents for biomedical research and drug discovery, including Membrane Lipid Strips for protein-lipid interaction assays; PIP3 Mass ELISA for PI(3,4,5)P3 detection; lipid antibodies; Hyaluronidase Activity ELISA; neuroscience resources for nervous system studies; and cell membrane resources for lipid-protein interactions and membrane analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Echelon Biosciences company profile →
Alderys
HQ: France
Website
- Description: Provider of innovative biological engineering approaches to produce chemical compounds of economic interest from renewable plant resources, including nutrients via rectified biosynthetic routes, targeting convenience chemicals, cosmetics, and animal nutrition markets, with environmentally respectful industrial technological solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alderys company profile →
Abcam
HQ: United Kingdom
Website
- Description: Provider of antibodies, proteins, and kits and reagents for life science research, validated for research use to support scientific studies and facilitate experimental procedures. Helps researchers with breakthroughs in cancer, neurological disorders, infectious diseases, and metabolic disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Abcam company profile →
ReadyCell
HQ: Spain
Website
- Description: Provider of cell-based in vitro tools and drug discovery services, including: CacoReady, a ready-to-use Caco-2 kit for assessing intestinal permeability in preclinical studies; CacoGoblet, a Caco-2/HT-29 co-culture to evaluate intestinal absorption and anti-inflammatory drug efficacy; PreadyPort, MDCKII-based kits to study permeability and MDR1/BCRP efflux; PreadyTake, HEK293 transporter-overexpressing kits (MATE1, OCT2, OATP1B3).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ReadyCell company profile →
BIA Separations
HQ: Slovenia
Website
- Description: Provider of proprietary monolithic chromatography columns based on CIM Convective Interaction Media technology for production, purification, and analysis of large biomolecules, including viruses, plasmid DNA, exosomes, antibodies, bacteriophages, and large proteins. Offers CIMmultus preparative and CIMac analytical columns, PATfix analytical standards, and Cornerstone services and process development support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BIA Separations company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Celltrio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Celltrio
2.2 - Growth funds investing in similar companies to Celltrio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Celltrio
4.2 - Public trading comparable groups for Celltrio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →